Tradestie Institutional Equity Comparison Engine
IRIX vs CPIX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CPIX Overall Edge
CPIX Captures Institutional Edge (4โ0 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cumberland Pharmaceuticals Inc (CPIX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, IRIX trades at N/M Forward P/E with -5.4% operating margin (-7.4% YoY revenue) versus CPIX at 50.0x Forward P/E and -4.7% operating margin (-74.0% YoY). In options structure, IRIX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CPIX sits in BREAKDOWN (37th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
CPIX
IRIX N/M vs CPIX 50.0x Fwd P/E
Growth & Margin Winner
CPIX
Op Margin -5.4% vs -4.7% ยท YoY -7.4% vs -74.0%
Momentum & Technical Winner
CPIX
1Y -22.5% vs +149.3% ยท 52W Pos 8% vs 45%
Options & Structure Winner
CPIX
UNCLASSIFIED (N/A IV) vs BREAKDOWN (37th %ile IV)
IRIX
NASDAQ
Iridex Corp
Electromedical & Electrotherapeutic Apparatus
$0.69
-0.32% 1D
Market Cap
$12.1M
1M Return
-15.57%
1Y Return
-22.49%
Forward P/E
N/M
Unified AI Score
51.8 / 100
HOLD
Tech 52.0
Fund 65.0
Flow 50.0
Mom 50.0
CPIX
NASDAQ
Cumberland Pharmaceuticals Inc
Pharmaceutical Preparations
$5.21
-11.39% 1D
Market Cap
$88.2M
1M Return
-27.44%
1Y Return
+149.28%
Forward P/E
50.0x
Unified AI Score
49.1 / 100
HOLD
Tech 40.0
Fund 63.0
Flow 72.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
IRIX -22.49%
CPIX +149.28%
Spread: +171.77 pp (CPIX Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | IRIX Revenue | CPIX Revenue | IRIX Op. Margin | CPIX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $40M | $30M | -20.7% | -28.7% | IRIX |
| FY2020 | N/A | $40M | N/A | -17.8% | CPIX |
| FY2021 | $40M | $40M | -18.1% | -21.9% | IRIX |
| FY2022 | $60M | $40M | -13.2% | -13.6% | IRIX |
| FY2023 | $50M | $40M | -19.3% | -24.2% | IRIX |
| FY2024 | $50M | $40M | -17.1% | -17.0% | CPIX |
| FY2025 | N/A | $40M | N/A | -6.3% | CPIX |
| FY2026 | $50M | N/A | -4.9% | N/A | IRIX |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | IRIX | CPIX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $12.1M | $88.2M | Larger Scale | CPIX |
| Trailing P/E Ratio Valuation | N/M | 50.0x | Lower Multiple | CPIX |
| Forward P/E Ratio Valuation | N/M | 50.0x | Lower Multiple | CPIX |
| Revenue Growth (YoY) Growth | -7.4% | -74.0% | Higher Growth | IRIX |
| Operating Margin (TTM) Profitability | -5.4% | -4.7% | Higher Margin | CPIX |
| Net Profit Margin Profitability | -6.9% | 148.6% | Higher Margin | CPIX |
| Return on Equity (ROE) Capital Efficiency | -73.2% | -3.4% | Higher ROE | CPIX |
| 52-Week Range Position Momentum | 8% ($1โ$2) | 45% ($2โ$9) | Stronger Trend | CPIX |
| Beta / 30D Volatility Risk Regime | 0.66ฮฒ ยท 58% Vol | 0.44ฮฒ ยท 222% Vol | Lower Realized Risk | IRIX |
| Unified Institutional Score Composite Signal | 51.8 / 100 (HOLD) | 49.1 / 100 (HOLD) | Higher Composite | IRIX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full IRIX vs CPIX Buy Guide
IRIX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CPIX
BREAKDOWN
87d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
37th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither IRIX nor CPIX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.